CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.

Keywords

Vascular endothelial growth factor, Cancer research, Ovarian cancer, Medicine, VEGF receptors

References

• Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian CancerSue Halpern — 2004
• Role of the Tumor Microenvironment in Mediating Response to Anti-angiogenic TherapyYoung Do Jung, Syed A. Ahmad, Yoshito Akagi — 2004
• A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.Antonino Passaniti, Rosanne M. Taylor, Роберто Пили — 1992
• The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.Robert Möhle, Frank Bautz, Shahin Rafii — 1998
• In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment.Chang H. Kim, Hal E. Broxmeyer — 1998
• Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthDavid Lyden, Koichi Hattori, Sérgio Dias — 2001
• Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.Anne Marfaing‐Koka, Odile Devergne, G Gorgone — 1995
• Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cellsWeiping Zou, Véronique Machelon, Aurore Coulomb-L'Hermin — 2001
• Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.Sandra A. Rempel, S Dudas, Shugang Ge — 2000
• Angiogenesis in cancer and other diseasesPeter Carmeliet, Rakesh K. Jain — 2000
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisPeter Carmeliet, Yuval Dor, Jean-Marc Herbert — 1998
• Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis.Raymond M. Shaheen, Darren W. Davis, Wenbiao Liu — 1999
• Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by β-Chemokines Rather Than IL-121Weiping Zou, Jozef Borvak, Florentina Marches — 2000
• Optimal Chemotactic Responses of Leukemic T Cells to Stromal Cell-Derived Factor-1 Requires the Activation of Both Class IA and IB Phosphoinositide 3-Kinases1Adam P. Curnock, Yannis Sotsios, Karen L. Wright — 2003
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsPeter Carmeliet, Lieve Moons, Aernout Luttun — 2001
• Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.Robin E. Bachelder, Melissa A. Wendt, Arthur M. Mercurio — 2002
• The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entryConrad C. Bleul, Michael Farzan, Hyeryun Choe — 1996
• Increased immunoreactivity of stromal cell-derived factor‐1 and angiogenesis in asthmaMakoto Hoshino, Nozomi Aoike, Miki Takahashi — 2003
• Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHLPeter Staller, Jitka Sulitkova, Joanna Lisztwan — 2003
• Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells.Jan Heidemann, Hitoshi Ogawa, Parvaneh Rafiee — 2004

Cited by

• 17-AAG, a Hsp90 inhibitor, attenuates the hypoxia-induced expression of SDF-1α and ILK in mouse RPE cells隆司 古川 — 2010
• Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.Ileana Cuevas, Nancy Boudreau — 2009
• Assessment of the humoral immune response to cancer.Chris Pearson, Carl Thwaite, Nick Russel — 2012
• Etude phénotypique des cellules endométriosiques profondesMahaut Leconte — 2012
• p53 mutation in the genesis of metastasis.W. Andrew Yeudall — 2014
• The use of proteomics techniques to identify potential markers of early stage colorectal cancerD O'Neil — 2011
• Lymphocytes T CD4 et immunité anti-tumorale naturelle : impact de la chimiothérapie, émergence de lymphocytes T CD4 cytotoxiquesI. Peguillet — 2014
• Modulation of bone marrow-derived endothelial progenitor cells by vascular endothelial growth inhibitor (VEGI)P. Liang — 2011
• Network biology approaches reveal a link between ribosome biogenesis and metabolic reprogramming in ageing skeletal musclesKim Clarke — 2014
• Sonic hedgehog stimulates the recruitment of endothelial progenitor cells.Karolina Podolska, Agnieszka Lipiec, Karolina Hajdukiewicz — 2013
• Developing novel strategies for treating esophageal cancer: Dendritic cells immunotherapy, T cell responses and an exploration of the tumor microenvironmentF. Milano — 2007
• Rôle des progéniteurs dans l’hypertension artérielle pulmonaire humaine et expérimentaleNatalia Gambaryan — 2011
• Regulation of endometrial regeneration; mechanisms contributing to repair and restoration of tissue integrity following mensesF. Cousins — 2014
• Etude de deux chimiokines CXCL12/SDF-1 et fractalkine (FKN)/CX3CL1 dans le cancer épithélial des ovairesSalam Nasreddine — 2011
• The role of the chemokine receptor CXCR4 in EGFRvIII-expressing breast cancerMassod Rahimi — 2009
• Impact d’un gain de fonction de Cxcr4 sur le développement et la compartimentalisation périphérique des lymphocytesVincent Biajoux — 2013
• A novel multi-target cancer therapy based on destabilization of short-lived mRNAsFelicitas Rataj — 2014
• MS-275 (ENTINOSTAT) PROMOTES SUSTAINED TUMOR REGRESSION IN THE CONTEXT OF BOOSTING ONCOLYTIC IMMUNOTHERAPYAndrew Nguyen — 2013
• Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.Paramita Ray, Sarah A. Lewin, Laura Anne Mihalko — 2011
• The inflammatory infiltrate of high-grade serous carcinoma omental metastasisGemma Everitt — 2014

Related papers

• Expression of total vascular endothelial growth factor (VEGF) and inhibitory isoforms of VEGF in head and neck squamous cell carcinomaMark D. Wilkie, Shilpa Santosh, Maxine S. Emmett — 2012
• Serum vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1) and sVEGFR-2 in systemic sclerosis patients: Relation to clinical manifestations and capillaroscopy findingsSaeedeh Shenavandeh, Taraneh Tarakemeh, Eskandar Kamali Sarvestani — 2017
• The Effect of VEGF (Vascular endothelial growth factor) on Endothelial Cells in Pathogenesis of PreeclampsiaYong-Kyun Cho, 이홍균 — 2002
• The effect of AD-VEGF-siRNA on the expression of vascular endothelial growth factor in osteosarcoma-bearing nude miceHuaming, Xue, Jiong — 2008
• Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment?Jacob Bruinius, Karl Dykema, Sabrina L. Noyes — 2019
• Vascular Endothelial Growth Factor (VEGF) In Aqueous Humor: Prognostic Factor In Uveal MelanomaMJ JAGER, CJ M Krose, Wieke Zuidervaart — 2002
• Comparison of Serum Concentrations of Bevacizumab and Vascular Endothelial Growth Factor (VEGF) Levels in Laser and Bevacizumab Treated ROP PatientsLingkun Kong, Amit Bhatt, Ann B. Demny — 2014
• Application of Vascular Endothelial Growth Factor in Spinal Cord Injury(review)Yang Zheng — 2011